The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Benign Prostatic Hyperplasia Devices Market Research Report 2025

Global Benign Prostatic Hyperplasia Devices Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1891510

No of Pages : 82

Ask Your Query
Synopsis
Benign prostatic hyperplasia (BPH) is a urological disorder characterized by non-cancerous proliferation of prostate gland cells. This condition causes the gland to enlarge and, as a result, press against the urethra, constricting urine flow. This disorder is associated with aging, hormone imbalances, and abnormal cell growth.
The global Benign Prostatic Hyperplasia Devices market was valued at US$ 381 million in 2023 and is anticipated to reach US$ 507.6 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
The global benign prostatic hyperplasia market is expected to show considerable growth during the forecast period. This is attributed to rising geriatric population, increased awareness for prostate cancer and other urological disorders. However, the factors such as dearth of urologist in developing economies and lack of awareness regarding various urological diseases can hinder the growth of the market in the coming years. North America is account for the largest share of the benign prostatic hyperplasia market in 2016 due to high prevalence rate of benign prostatic hyperplasia. However, Asia is the fastest growing market due to the rise in various urological disorders and complications
This report aims to provide a comprehensive presentation of the global market for Benign Prostatic Hyperplasia Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Benign Prostatic Hyperplasia Devices.
Report Scope
The Benign Prostatic Hyperplasia Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Benign Prostatic Hyperplasia Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Benign Prostatic Hyperplasia Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lumenis
Olympus corporation
Urologix
Boston Scientific corporation
Lisa Laser
Medifocus
Neotrac
ProArc Medical LTD
Urotech GMBH
Segment by Type
Transurethral Resection of the Prostate (TURP)
Transurethral Microwave Therapy (TUMT)
Transurethral Needle Ablation of the Prostate (TUNA)
Laser Surgery
Prostatic Stenting
Others
Segment by Application
Hospitals and Clinics
Ambulatory Surgical Centers(ASC)
Home
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Benign Prostatic Hyperplasia Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Benign Prostatic Hyperplasia Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Benign Prostatic Hyperplasia Devices Market Overview
1.1 Product Overview and Scope of Benign Prostatic Hyperplasia Devices
1.2 Benign Prostatic Hyperplasia Devices Segment by Type
1.2.1 Global Benign Prostatic Hyperplasia Devices Market Value Comparison by Type (2024-2030)
1.2.2 Transurethral Resection of the Prostate (TURP)
1.2.3 Transurethral Microwave Therapy (TUMT)
1.2.4 Transurethral Needle Ablation of the Prostate (TUNA)
1.2.5 Laser Surgery
1.2.6 Prostatic Stenting
1.2.7 Others
1.3 Benign Prostatic Hyperplasia Devices Segment by Application
1.3.1 Global Benign Prostatic Hyperplasia Devices Market Value by Application: (2024-2030)
1.3.2 Hospitals and Clinics
1.3.3 Ambulatory Surgical Centers(ASC)
1.3.4 Home
1.3.5 Others
1.4 Global Benign Prostatic Hyperplasia Devices Market Size Estimates and Forecasts
1.4.1 Global Benign Prostatic Hyperplasia Devices Revenue 2019-2030
1.4.2 Global Benign Prostatic Hyperplasia Devices Sales 2019-2030
1.4.3 Global Benign Prostatic Hyperplasia Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Benign Prostatic Hyperplasia Devices Market Competition by Manufacturers
2.1 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Benign Prostatic Hyperplasia Devices Average Price by Manufacturers (2019-2024)
2.4 Global Benign Prostatic Hyperplasia Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Benign Prostatic Hyperplasia Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Benign Prostatic Hyperplasia Devices, Product Type & Application
2.7 Benign Prostatic Hyperplasia Devices Market Competitive Situation and Trends
2.7.1 Benign Prostatic Hyperplasia Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Benign Prostatic Hyperplasia Devices Players Market Share by Revenue
2.7.3 Global Benign Prostatic Hyperplasia Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Benign Prostatic Hyperplasia Devices Retrospective Market Scenario by Region
3.1 Global Benign Prostatic Hyperplasia Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Benign Prostatic Hyperplasia Devices Global Benign Prostatic Hyperplasia Devices Sales by Region: 2019-2030
3.2.1 Global Benign Prostatic Hyperplasia Devices Sales by Region: 2019-2024
3.2.2 Global Benign Prostatic Hyperplasia Devices Sales by Region: 2025-2030
3.3 Global Benign Prostatic Hyperplasia Devices Global Benign Prostatic Hyperplasia Devices Revenue by Region: 2019-2030
3.3.1 Global Benign Prostatic Hyperplasia Devices Revenue by Region: 2019-2024
3.3.2 Global Benign Prostatic Hyperplasia Devices Revenue by Region: 2025-2030
3.4 North America Benign Prostatic Hyperplasia Devices Market Facts & Figures by Country
3.4.1 North America Benign Prostatic Hyperplasia Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Benign Prostatic Hyperplasia Devices Sales by Country (2019-2030)
3.4.3 North America Benign Prostatic Hyperplasia Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Benign Prostatic Hyperplasia Devices Market Facts & Figures by Country
3.5.1 Europe Benign Prostatic Hyperplasia Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Benign Prostatic Hyperplasia Devices Sales by Country (2019-2030)
3.5.3 Europe Benign Prostatic Hyperplasia Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Benign Prostatic Hyperplasia Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Benign Prostatic Hyperplasia Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Benign Prostatic Hyperplasia Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Benign Prostatic Hyperplasia Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Benign Prostatic Hyperplasia Devices Market Facts & Figures by Country
3.7.1 Latin America Benign Prostatic Hyperplasia Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Benign Prostatic Hyperplasia Devices Sales by Country (2019-2030)
3.7.3 Latin America Benign Prostatic Hyperplasia Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Benign Prostatic Hyperplasia Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Benign Prostatic Hyperplasia Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Benign Prostatic Hyperplasia Devices Sales by Type (2019-2030)
4.1.1 Global Benign Prostatic Hyperplasia Devices Sales by Type (2019-2024)
4.1.2 Global Benign Prostatic Hyperplasia Devices Sales by Type (2025-2030)
4.1.3 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2019-2030)
4.2 Global Benign Prostatic Hyperplasia Devices Revenue by Type (2019-2030)
4.2.1 Global Benign Prostatic Hyperplasia Devices Revenue by Type (2019-2024)
4.2.2 Global Benign Prostatic Hyperplasia Devices Revenue by Type (2025-2030)
4.2.3 Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Type (2019-2030)
4.3 Global Benign Prostatic Hyperplasia Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Benign Prostatic Hyperplasia Devices Sales by Application (2019-2030)
5.1.1 Global Benign Prostatic Hyperplasia Devices Sales by Application (2019-2024)
5.1.2 Global Benign Prostatic Hyperplasia Devices Sales by Application (2025-2030)
5.1.3 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2019-2030)
5.2 Global Benign Prostatic Hyperplasia Devices Revenue by Application (2019-2030)
5.2.1 Global Benign Prostatic Hyperplasia Devices Revenue by Application (2019-2024)
5.2.2 Global Benign Prostatic Hyperplasia Devices Revenue by Application (2025-2030)
5.2.3 Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Application (2019-2030)
5.3 Global Benign Prostatic Hyperplasia Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Lumenis
6.1.1 Lumenis Corporation Information
6.1.2 Lumenis Description and Business Overview
6.1.3 Lumenis Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Lumenis Benign Prostatic Hyperplasia Devices Product Portfolio
6.1.5 Lumenis Recent Developments/Updates
6.2 Olympus corporation
6.2.1 Olympus corporation Corporation Information
6.2.2 Olympus corporation Description and Business Overview
6.2.3 Olympus corporation Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Olympus corporation Benign Prostatic Hyperplasia Devices Product Portfolio
6.2.5 Olympus corporation Recent Developments/Updates
6.3 Urologix
6.3.1 Urologix Corporation Information
6.3.2 Urologix Description and Business Overview
6.3.3 Urologix Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Urologix Benign Prostatic Hyperplasia Devices Product Portfolio
6.3.5 Urologix Recent Developments/Updates
6.4 Boston Scientific corporation
6.4.1 Boston Scientific corporation Corporation Information
6.4.2 Boston Scientific corporation Description and Business Overview
6.4.3 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Product Portfolio
6.4.5 Boston Scientific corporation Recent Developments/Updates
6.5 Lisa Laser
6.5.1 Lisa Laser Corporation Information
6.5.2 Lisa Laser Description and Business Overview
6.5.3 Lisa Laser Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Lisa Laser Benign Prostatic Hyperplasia Devices Product Portfolio
6.5.5 Lisa Laser Recent Developments/Updates
6.6 Medifocus
6.6.1 Medifocus Corporation Information
6.6.2 Medifocus Description and Business Overview
6.6.3 Medifocus Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Medifocus Benign Prostatic Hyperplasia Devices Product Portfolio
6.6.5 Medifocus Recent Developments/Updates
6.7 Neotrac
6.6.1 Neotrac Corporation Information
6.6.2 Neotrac Description and Business Overview
6.6.3 Neotrac Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Neotrac Benign Prostatic Hyperplasia Devices Product Portfolio
6.7.5 Neotrac Recent Developments/Updates
6.8 ProArc Medical LTD
6.8.1 ProArc Medical LTD Corporation Information
6.8.2 ProArc Medical LTD Description and Business Overview
6.8.3 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Product Portfolio
6.8.5 ProArc Medical LTD Recent Developments/Updates
6.9 Urotech GMBH
6.9.1 Urotech GMBH Corporation Information
6.9.2 Urotech GMBH Description and Business Overview
6.9.3 Urotech GMBH Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Urotech GMBH Benign Prostatic Hyperplasia Devices Product Portfolio
6.9.5 Urotech GMBH Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Benign Prostatic Hyperplasia Devices Industry Chain Analysis
7.2 Benign Prostatic Hyperplasia Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Benign Prostatic Hyperplasia Devices Production Mode & Process
7.4 Benign Prostatic Hyperplasia Devices Sales and Marketing
7.4.1 Benign Prostatic Hyperplasia Devices Sales Channels
7.4.2 Benign Prostatic Hyperplasia Devices Distributors
7.5 Benign Prostatic Hyperplasia Devices Customers
8 Benign Prostatic Hyperplasia Devices Market Dynamics
8.1 Benign Prostatic Hyperplasia Devices Industry Trends
8.2 Benign Prostatic Hyperplasia Devices Market Drivers
8.3 Benign Prostatic Hyperplasia Devices Market Challenges
8.4 Benign Prostatic Hyperplasia Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock